A Comparison of Psoriasis Severity in Pediatric Patients Treated With Methotrexate vs Biologic Agents

Autor: Bronckers, IMGJ, Paller, AS, West, DP, Lara-Corrales, I, Tollefson, MM, Tom, WL, Hogeling, M, Belazarian, L, Zachariae, C, Mahe, E, Siegfried, E, Blume-Peytavi, U, Szalai, Z, Vleugels, RA, Holland, K, Murphy, R, Puig, L, Cordoro, KM, Lambert, J, Alexopoulos, A, Mrowietz, U, Kievit, W, Seyger, MMB, Psoriasis Investigator Grp, Pediat Dermatology Res Alliance, European Working Grp Pediat

Publikováno v: JAMA Dermatology
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

This cohort study compares the use of methotrexate vs biologic agents in children with moderate to severe psoriasis. Question What is the association between use of methotrexate vs biologics and psoriasis severity and drug survival (rate and duration

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::559224e63ced38aac1aa86eb6d06df87
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=1647